Can power doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy?

European Urology

Volumn 46, Issue 4, 2004, Pages 451-456

  Remzi, Mesut ^a   Dobrovits, Michael ^a   Reissigl, Andreas ^b   Ravery, Vincent ^c   Waldert, Mattias ^a   Wiunig, Christian ^b   Fong, Yan Kit ^a   Djavan, Bob ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b Bregenz ^*  (Austria)

^c Paris France   (France)

Author keywords

Biopsy; Biopsy technique; Power Doppler; Prostate cancer; Ultrasound

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EVALUATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; TRANSRECTAL ULTRASONOGRAPHY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BIOPSY; ENDOSONOGRAPHY; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECTUM; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 4444301437     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2004.06.002     Document Type: Article

References (30)

1. Djavan B., Remzi M., Schulman C.C., Marberger M., Zlotta A.R. Repeat prostate biopsies: who, how and when? A review. Eur. Urol. 42:2002;93-103
2. Aus G., Abbou C.C., Pacik D., Schmid H.P., van Poppel H., Wolff J.M., et al. EAU Working Group on Oncological Urology. EAU guidelines on prostate cancer. Eur. Urol. 40:2001;97-101
3. Norberg M., Egevad L., Holmberg L., Sparen P., Norlen B.J., Busch C. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology. 50:1997;562-566
4. Mettlin C.J., Murphy G.P. Why is the prostate cancer death rate declining in the United States? Cancer. 82:1998;249-251
5. Djavan B, Remzi M, Seitz C, Anagnostou T, Dobrovits M, Harik M, et al. The Vienna nomogram: A novel biopsy strategy defining the optimal number of cores based on PSA, age and prostate volume. J Urol 2003;169(Suppl 4),A:462, 2003.
6. Remzi M., Djavan B., Dobrovits M., Waldert M., Marberger M. Prospektive Validierung einer neuen modifizierten Prostatarebiopsiestrategy. Wiener Klin Wochenschrift. 115(Suppl 1):2003;A129
7. Jackson M.W., Bentel J.M., Tilley W.D. Vascular endothelial growth factor (VEGF) expression in prostatic cancer and benign prostatic hyperplasia. J. Urol. 157:1997;2323-2328
8. Bilger S.A., Deering R.E., Brawer M.K. Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum. Pathol. 24:1993;220-226
9. Donnelly E.F., Geng L., Wojcicki W.E., Fleischer A.G., Hallahan D.E. Quantified power Doppler US of tumor blood flow correlates with microscopic quantification of tumor blood vessels. Radiology. 219:2001;166-170
10. Remzi M., Djavan B., Wammack R., Momeni M., Seitz C., Erne B., et al. Can total and transition zone volume of the prostate determine whether to perform a repeat biopsy. Urology. 61:2003;161-166
11. Zackrisson B., Aus G., Lilja H., Lodding P., Pihl C.G., Hugosson J. Follow-up of men with elevated prostate specific antigen and one set of benign biopsies at prostate cancer screening. Eur Urol. 43:2003;327-332
12. Mazal P.R., Haitel A., Windischberger C., Djavan B., Sedivy R., Moser E., et al. Spatial distribution of prostate cancer undetected on initial needle biopsies. Eur. Urol. 39:2001;662-668
13. Chang J.J., Shinohara K., Bhargava V., Presti J.C. Jr. Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J. Urol. 160:1998;2111-2114
14. Ravery V., Goldblatt L., Royer B., Blanc E., Toublanc M., Boccon-Gibod L. Extensive biopsy protocol improves the detection rate of prostate cancer. J. Urol. 164:2000;393-396
15. Stewart C.S., Leibovich B.C., Weaver A.L., Lieber M.M. Prostate cancer diagnosis using saturation needle biopsy technique after previous negative sextant biopsies. J. Urol. 166:2001;86-91
16. Djavan B., Zlotta A.R., Remzi M., Ghawidel K., Basharkhah A., Schulman C.C., et al. Optimal predictors of prostate cancer in repeat prostate biopsy: a prospective study of 1051 men. J. Urol. 163:2000;1144-1148
17. Djavan B., Waldert M., Zlotta A.R., Dobronski P., Seitz C., Remzi M., et al. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J. Urol. 166:2001;856-860
18. Guercini F., Solivetti F.M., Dimitri M., D'Ascenzo R., Micali F. Color Doppler in the diagnosis of malignant prostatic neoplasia. Premiminary resuls. Arch. Ital. Urol. Nefrol. Androl. 63(Suppl 2):1991;29-33
19. Rifkin M.D., Sudakoff G.S., Alexander A.A. Prostate: techniques, results, and potential applications of color Doppler US scanning. Radiology. 186:1993;509-513
20. Bergonzi M., Bonfioli C., Motta F., Urani A. Color-Doppler in transrectal echography of the prostate. Peliminary results. Radiol. Med. (Torino). 85(Suppl 1):1993;124-128
21. Cornud F., Belin X., Piron D., Chretien Y., Flam T., Casanova J.M., et al. Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesions. Urology. 49:1997;709-715
22. Halpern E.J., Strup S.E. Using gray-scale and color and power Doppler sonography to detect prostatic cancer. Am. J. Roentgenol. 174:2000;623-627
23. Halpern E.J., Frauscher F., Strup S.E., Nazarian L.N., O'Kane P., Gomella L.G. Prostate: High-Frequency Doppler US Imaging for Cancer Detection. Radiology. 225:2002;71-77
24. Frauscher F., Klauser A., Volgger H., Halpern E.J., Pallwein L., Steiner H., et al. Comparison of contrast enhanced color doppler trargeted biopsy with conventional systematic biopsy: Impact on prostate cancer detection. J. Urol. 167:2002;1648-1652
25. Roy C, Buy X, Lang H, Saussine C, Jacqmin D. Contrast enhances color Doppler endorectal sonography of prostate: efficiency for detecting peripheral zone tumors and role of biopsy procedure. J Urol 170:69-72, 2003-06-18.
26. Moskalik A.P., Rubin M.A., Wojno K.E., Bree R., Rubin J.M., Fowlkes J.B., et al. Analysis of three-dimensional Doppler ultrasonographic quantitative measures for the discrimination of prostate cancer. J. Ultrasound Med. 20(7):2001;713-722
27. Leventis A.K., Shariat S.F., Utsunomiya T., Slawin K.M. Characteristics of normal prostate vascular anatomy as displayed by Power Doppler. Prostate. 46:2001;281-288
28. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am. J. Pathol. 147:1995;9-19
29. Gee M.S., Saunders H.M., Lee J.C., Sanzo J.F., Jenkins W.T., Evans S.M., et al. Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations. Cancer Res. 61(7):2001;2974-2982
30. Lassau N., Koscielny S., Opolon P., De Baere T., Peronneau P., Leclere J., et al. Evaluation of contrast-enhanced color Doppler ultrasound for the quantification of angiogenesis in vivo. Invest Radiol. 36(1):2001;50-55